Brief: Cereno Scientific Extends Patent Protection For Drug Candidate CS1 In U.S.
17/03/2025 07:32
March 17 (Reuters) - Cereno Scientific AB CRNOSb.ST: CERENO SCIENTIFIC EXTENDS PATENT PROTECTION FOR DRUG CANDIDATE CS1 IN THE US AND HAS FILED TO EXTEND MARKET EXCLUSIVITY TO 2045 Source text: ID:nWkr8mkWz8 Further company coverage: [CRNOSb.ST] (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Cereno Scientific AB
See all newsBrief: Cereno Scientific Carries Out Directed Share Issue Of SEK 60 Mln
Brief: Cereno Scientific Strengthens Patent Protection For Cs1 In Canada
Sweden's Cereno Scientific Q1 net loss widens amid clinical development
Brief: Cereno Scientific Q1 Loss After Financial Items SEK 28.6 Mln
Brief: Cereno Enters Collaboration With PHA Europe & Global